Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc

AIDS. 2010 Jun 1;24(9):1382-4. doi: 10.1097/QAD.0b013e328338b7a6.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cyclohexanes / therapeutic use*
  • Drug Resistance, Viral / genetics*
  • HIV Fusion Inhibitors / therapeutic use*
  • HIV Infections / drug therapy*
  • HIV Infections / genetics
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Humans
  • Male
  • Maraviroc
  • Phenotype
  • Triazoles / therapeutic use*

Substances

  • Cyclohexanes
  • HIV Fusion Inhibitors
  • Triazoles
  • Maraviroc